NewBridge Pharmaceuticals
PrivateLast Round
Corporate Funding
May 20, 2013
Est. Valuation
$83.33M
Total Funding Raised
$56M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NewBridge Pharmaceuticals is a specialty pharmaceutical company that provides a platform to in-license and commercialize innovative therapeutics in the Middle East and North Africa (MENA) region.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NewBridge Pharmaceuticals Comparables
Compare NewBridge Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vector Pharma | 79% | |
| Cigalah Group | 74% | |
| SABIC | 69% |
NewBridge Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 20, 2013 | ||||
| Series B | Sep 20, 2010 |
NewBridge Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KLSC | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased by 34% MoM.
- Aug 21, 2026
Monthly visitors grew 71% MoM, reaching 2.1K.
NewBridge Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NewBridge Pharmaceuticals's valuation, stock price, and market status.
Is NewBridge Pharmaceuticals a public or private company?
NewBridge Pharmaceuticals is a private company.
What is the current stock price of NewBridge Pharmaceuticals?
NewBridge Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks NewBridge Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NewBridge Pharmaceuticals worth (valuation)?
NewBridge Pharmaceuticals's valuation is estimated at $83.3M based on funding round data.
Can I buy NewBridge Pharmaceuticals stock?
NewBridge Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NewBridge Pharmaceuticals's last funding round?
NewBridge Pharmaceuticals's most recent funding round was Corporate Funding on May 20, 2013.
Who are the main investors in NewBridge Pharmaceuticals?
Key investors in NewBridge Pharmaceuticals include KLSC.
Will NewBridge Pharmaceuticals IPO soon?
No public IPO plans have been announced for NewBridge Pharmaceuticals.
How can I track NewBridge Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in NewBridge Pharmaceuticals's shares on secondary markets.